loading

Apogee Therapeutics Inc (APGE) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
15.96%
73.17
63.10 58.69 44.12 38.18
Operating Income/Loss
15.96%
-73.17
-63.10 -58.69 -44.12 -38.18
Income/Loss From Continuing Operations Before Tax
19.49%
-66.02
-55.26 -49.02 -33.82 -32.09
Income Tax Expense/Benefit
13.25%
0.072
0.083 - - -
Income/Loss From Continuing Operations After Tax
19.44%
-66.10
-55.34 -49.02 -33.82 -32.09
Net Income/Loss
19.44%
-66.10
-55.34 -49.02 -33.82 -32.09
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.40%
58.43
58.20 56.80 56.52 50.19
Diluted Average Shares
0.40%
58.43
58.20 56.80 56.52 50.19
Basic Earnings Per Share
18.95%
-1.13
-0.95 -0.86 -0.60 -0.64
Diluted Earnings Per Share
18.95%
-1.13
-0.95 -0.86 -0.60 -0.64
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.77
price up icon 0.96%
$84.83
price up icon 1.01%
$24.95
price down icon 7.52%
$103.16
price down icon 1.99%
$133.82
price up icon 1.23%
biotechnology ONC
$300.31
price down icon 3.05%
자본화:     |  볼륨(24시간):